Today EBE and EuropaBio’s Joint Rare Diseases and Orphan Medicinal Products Task Force released an assessment of the EU’s Orphan Medicinal Products (OMP) Regulation evaluating the extent to which this legislation has impacted research into rare diseases and the availability of new medicines to treat rare diseases over the last ten years.
EuropaBio welcomes commitments made at this week’s Competitiveness Council of Ministers in Luxembourg on an enhanced patent system to boost innovative European industry with a special focus on the needs of SMEs but stresses the importance of swift, supportive action from the member states.
Next week more than 300 high-level policy makers, senior industry figures, academics, NGOs and journalists will meet in Edinburgh for EFIB, Europe’s leading event on Industrial Biotechnology and the bio-based economy.
Today’s unveiling by Commissioner Geoghegan-Quinn and Vice President Tajani, of the Commission’s plans to turn Europe into an ‘Innovation Union’ by 2020 is welcomed by EuropaBio’s members from across the healthcare, agricultural and industrial biotechnology sectors.
Yesterday, a new High-Level Group on Key Enabling Technologies (KET) was officially inaugurated by the European Commission’s Vice-President Antonio Tajani, Vice-President Neelie Kroes and Commissioner Maire Geoghegan-Quinn.